Precision medicine for KRAS Wild-Type pancreatic adenocarcinomas

KRAS mutation is the most common molecular alteration in pancreatic adenocarcinoma (PDAC), and around 10% of patients harbor KRAS wild-type tumors (KRASWT).

Source: European Journal of Cancer - December 15, 2023 Category: Cancer & Oncology Authors: Imen Ben-Ammar, Adrien Rousseau, R émy Nicolle, Anthony Tarabay, Valérie Boige, Marine Valery, Thomas Pudlarz, David Malka, Maximiliano Gelli, Elena Fernandez-De-Sevilla, Alina Fuerea, Marie-Laure Tanguy, Etienne Rouleau, Rémy Barbe, Jacques R.R Mathie Tags: Original Research Source Type: research